Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
39.80
+0.46 (1.17%)
Nov 21, 2024, 4:00 PM EST - Market closed
Xenon Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
259
Market Cap
3.03B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Surgery Partners | 2.99B |
Amedisys | 2.32B |
LivaNova | 1.24B |
HUTCHMED (China) | 610.81M |
Inari Medical | 574.50M |
Veracyte | 425.33M |
Merus | 35.93M |
XENE News
- 8 days ago - Xenon to Present at Upcoming Investor Conferences - GlobeNewsWire
- 8 days ago - Xenon Pharmaceuticals Inc. (XENE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Xenon Reports Q3 2024 Financial Results and Business Update - GlobeNewsWire
- 16 days ago - Xenon to Report Q3 2024 Financial Results on November 12, 2024 - GlobeNewsWire
- 7 weeks ago - Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference - GlobeNewsWire
- 2 months ago - Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress - GlobeNewsWire
- 3 months ago - Xenon Pharmaceuticals, Inc. (XENE) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Xenon Reports Q2 2024 Financial Results and Business Update - GlobeNewsWire